Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) disclosed today that Angelini Labopharm, LLC, its joint venture (JV) with Gruppo Angelini which markets and sells OLEPTRO™ in the United States, has reduced its sales force from...
Labopharm JV Announces Major Layoffs
- Paladin Labs to Acquire Labopharm for $20 Million
- Labopharm Terminates Angelini JV Agreement, Grants Angelini Sole OLEPTRO Commercialization Right
- Labopharm Announces 2nd Round of Layoffs in 2011
- Labopharm JV Announces Major Layoffs
- Labopharm to Renegotiate JV Agreement and Explores Assets Sale
- Labopharm Announces New Round of Layoff and New CFO